Fritextsökning
Innehållstyper
-
Vaccin mot borrelia kan bli verklighet
Franska Valneva, med tillverkning i Sverige, och amerikanska Pfizer inleder en fas III-studie med ett vaccin mot borrelia. Studien startar redan i år.
-
Ny modell ska identifiera rätt dos litium vid bipolär sjukdom
Ny forskning vid Karolinska institutet kan bidra till att lösa ett stort problem inom behandling av bipolär sjukdom: att hitta rätt dos litium för varje patient.
-
Platelet analysis in whole blood
The new Multiplate analyzer from Triolab uses impedance aggregometry to measure the effects of platelet inhibitors on whole blood.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Långsiktig effekt av hormonbehandling vid bröstcancer utredd
Hormonbehandling har en skyddande effekt mot spridd cancer vid både så kallad Luminal A och Luminal B bröstcancersubtyp. Det visar ny forskning från Karolinska institutet.
-
Cancerdödande protein förstärks – med hjälp av spindeltråd
Länge har stora förhoppningar knutits till proteinet p53 som behandling mot cancer, men problemet är att kroppens celler tillverkar det i för liten mängd och at...
-
Astrazeneca får backning på cancerkandidat
FDA:s rådgivande kommitté menar att det behövs mer data kring läkemedelskandidaten olaparid mot äggstockscancer.
-
Hormones make children fat
A new Danish million project will define the connection between hormons and obesity amongst children.
-
New map of eye proteins
A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Life science in Stockholm
Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
-
Nu godkänns Hemlibra för hemofilibehandling
Roche får behandling för hemofili A godkänd av EU-kommissionen.
-
Medicon Valley cluster in brief
The Medicon Valley covers the Öresund region (Skåne and Sjaelland).
-
Vitamin D is mental health aid
Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.
-
Topp 10 mest sålda läkemedel
Top tio-listan av de läkemedel som sålt bäst på den amerikanska marknaden
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
Norwegian describes scrapie gene
Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.
-
Seminar program Biotech Forum
Here is the entire seminar program at Biotech Forum September 28-29th
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Sekvenseringsjätten BGI satsar på molnet
Analys och datalagring av DNA-sekvenser tar stora datorresurser i anspråk.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.